A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease (Q57499315)
Jump to navigation
Jump to search
scholarly article published in Clinical Neuropharmacology
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease |
scholarly article published in Clinical Neuropharmacology |
Statements
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease (English)
0 references
21
0 references
2
0 references
101-7
0 references